Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard Pollak

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
The New York Times on the Web|September 3, 1986
A bitter pill for epilepticsRichard Pollak
Journal of the American Podiatric Medical Association|January 20, 2021
Opioid-Free Recovery from Bunionectomy with HTX-011, a Dual-Acting Local Anesthetic Combining Bupivacaine and Meloxicam, as the Foundation of Non-Opioid Multimodal AnalgesiaRichard Pollak, Danlin Cai, Tong J Gan
Diabetes Care|May 27, 2003
The efficacy and safety of Dermagraft in improving the healing of chronic diabetic foot ulcers: results of a prospective randomized trialWilliam A Marston, Jason Hanft, Paul Norwood, et al.
Journal of the American Podiatric Medical Association|November 23, 2006
Treatment of toenail onychomycosis with oral terbinafine plus aggressive debridement: IRON-CLAD, a large, randomized, open-label, multicenter trialMaureen B Jennings, Richard Pollak, Lawrence B Harkless, et al.
Surgical Infections|May 4, 2005
An open-label, randomized study comparing efficacy and safety of intravenous piperacillin/tazobactam and ampicillin/sulbactam for infected diabetic foot ulcersLawrence Harkless, Jack Boghossian, Richard Pollak, et al.
Cutis|February 6, 2008
Toenail assessment tool for quantitation of visibly infected mycotic nail plate in onychomycosisAmir Tavakkol, Richard Pollak, Lawrence Harkless, et al.
International Wound Journal|October 12, 2025
Human Placenta-Derived Cells (PDA-002) in Diabetic Foot Ulcer Patients With and Without Peripheral Artery Disease: A Phase 2 Multi-Center, Randomised, Double-Blind, Placebo-Controlled TrialRichard Pollak, James Anderson, Bert Altmanshofer, et al.
Journal of Drugs in Dermatology : JDD|July 10, 2014
Efficacy and safety of once-daily luliconazole 1% cream in patients ≥12 years of age with interdigital tinea pedis: a phase 3, randomized, double-blind,vehicle-controlled studyMichael Jarratt, Terry Jones, Jeffrey Adelglass, et al.
International Wound Journal|January 31, 2017
Safety and efficacy of intramuscular human placenta-derived mesenchymal stromal-like cells (cenplacel [PDA-002]) in patients who have a diabetic foot ulcer with peripheral arterial diseaseStephanie C Wu, Richard Pollak, Robert G Frykberg, et al.
Pain and Therapy|July 20, 2020
Efficacy and Safety of Intravenously Administered Tramadol in Patients with Moderate to Severe Pain Following Bunionectomy: A Randomized, Double-Blind, Placebo-Controlled, Dose-Finding StudyNeil K Singla, Richard Pollak, Ira Gottlieb, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
The New York Times on the Web|September 3, 1986
A bitter pill for epilepticsRichard Pollak
Journal of the American Podiatric Medical Association|January 20, 2021
Opioid-Free Recovery from Bunionectomy with HTX-011, a Dual-Acting Local Anesthetic Combining Bupivacaine and Meloxicam, as the Foundation of Non-Opioid Multimodal AnalgesiaRichard Pollak, Danlin Cai, Tong J Gan
Diabetes Care|May 27, 2003
The efficacy and safety of Dermagraft in improving the healing of chronic diabetic foot ulcers: results of a prospective randomized trialWilliam A Marston, Jason Hanft, Paul Norwood, et al.
Journal of the American Podiatric Medical Association|November 23, 2006
Treatment of toenail onychomycosis with oral terbinafine plus aggressive debridement: IRON-CLAD, a large, randomized, open-label, multicenter trialMaureen B Jennings, Richard Pollak, Lawrence B Harkless, et al.
Surgical Infections|May 4, 2005
An open-label, randomized study comparing efficacy and safety of intravenous piperacillin/tazobactam and ampicillin/sulbactam for infected diabetic foot ulcersLawrence Harkless, Jack Boghossian, Richard Pollak, et al.
Cutis|February 6, 2008
Toenail assessment tool for quantitation of visibly infected mycotic nail plate in onychomycosisAmir Tavakkol, Richard Pollak, Lawrence Harkless, et al.
International Wound Journal|October 12, 2025
Human Placenta-Derived Cells (PDA-002) in Diabetic Foot Ulcer Patients With and Without Peripheral Artery Disease: A Phase 2 Multi-Center, Randomised, Double-Blind, Placebo-Controlled TrialRichard Pollak, James Anderson, Bert Altmanshofer, et al.
Journal of Drugs in Dermatology : JDD|July 10, 2014
Efficacy and safety of once-daily luliconazole 1% cream in patients ≥12 years of age with interdigital tinea pedis: a phase 3, randomized, double-blind,vehicle-controlled studyMichael Jarratt, Terry Jones, Jeffrey Adelglass, et al.
International Wound Journal|January 31, 2017
Safety and efficacy of intramuscular human placenta-derived mesenchymal stromal-like cells (cenplacel [PDA-002]) in patients who have a diabetic foot ulcer with peripheral arterial diseaseStephanie C Wu, Richard Pollak, Robert G Frykberg, et al.
Pain and Therapy|July 20, 2020
Efficacy and Safety of Intravenously Administered Tramadol in Patients with Moderate to Severe Pain Following Bunionectomy: A Randomized, Double-Blind, Placebo-Controlled, Dose-Finding StudyNeil K Singla, Richard Pollak, Ira Gottlieb, et al.
Pageof 2